Cargando…
Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review
Registered with PROSPERO (CRD42021267844) dated 14.07.2021. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13643-022-01983-8.
Autores principales: | Rai, Amit Kumar, Ahmad, Azeem, Mundada, Pallavi, Kumar V, Krishna, Yadav, Babita, Khanduri, Shruti, Chandrasekhararao, Bhogavalli, Srikanth, Narayanam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129058/ https://www.ncbi.nlm.nih.gov/pubmed/35610729 http://dx.doi.org/10.1186/s13643-022-01983-8 |
Ejemplares similares
-
AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India
por: Singh, Harbans, et al.
Publicado: (2022) -
Disease Characteristics, Care-Seeking Behavior, and Outcomes Associated With the Use of AYUSH-64 in COVID-19 Patients in Home Isolation in India: A Community-Based Cross-Sectional Analysis
por: Srikanth, Narayanam, et al.
Publicado: (2022) -
AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trial
por: Reddy, R. Govind, et al.
Publicado: (2020) -
AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot study
por: Gundeti, Manohar S., et al.
Publicado: (2022) -
Efficacy and safety of Guduchighana Vati in asymptomatic and mild-to-moderate cases of coronavirus disease-19: A randomized controlled pilot study
por: Shukla, Umesh, et al.
Publicado: (2020)